Annual Total Liabilities
$110.46 M
+$70.24 M+174.65%
December 31, 2023
Summary
- As of February 7, 2025, ZVRA annual total liabilities is $110.46 million, with the most recent change of +$70.24 million (+174.65%) on December 31, 2023.
- During the last 3 years, ZVRA annual total liabilities has risen by +$32.84 million (+42.31%).
- ZVRA annual total liabilities is now at all-time high.
Performance
ZVRA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$121.78 M
+$9.85 M+8.80%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA quarterly total liabilities is $121.78 million, with the most recent change of +$9.85 million (+8.80%) on September 30, 2024.
- Over the past year, ZVRA quarterly total liabilities has increased by +$11.32 million (+10.25%).
- ZVRA quarterly total liabilities is now -1.33% below its all-time high of $123.42 million, reached on March 1, 2016.
Performance
ZVRA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ZVRA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +174.7% | +10.3% |
| 3 y3 years | +42.3% | +10.3% |
| 5 y5 years | +18.4% | +10.3% |
ZVRA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1797.0% | at high | +2794.7% |
| 5 y | 5-year | at high | +1797.0% | at high | +2794.7% |
| alltime | all time | at high | +1797.0% | -1.3% | +2794.7% |
Zevra Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $121.78 M(+8.8%) |
| Jun 2024 | - | $111.93 M(+9.2%) |
| Mar 2024 | - | $102.47 M(-7.2%) |
| Dec 2023 | $110.46 M(+174.6%) | $110.46 M(+54.5%) |
| Sep 2023 | - | $71.51 M(+93.2%) |
| Jun 2023 | - | $37.02 M(+5.2%) |
| Mar 2023 | - | $35.19 M(-12.5%) |
| Dec 2022 | $40.22 M(+590.7%) | $40.22 M(+56.2%) |
| Sep 2022 | - | $25.76 M(+2.9%) |
| Jun 2022 | - | $25.02 M(+494.8%) |
| Mar 2022 | - | $4.21 M(-27.8%) |
| Dec 2021 | $5.82 M(-92.5%) | - |
| Dec 2021 | - | $5.82 M(+6.9%) |
| Sep 2021 | - | $5.45 M(-33.0%) |
| Jun 2021 | - | $8.13 M(+31.5%) |
| Mar 2021 | - | $6.18 M(-92.0%) |
| Dec 2020 | $77.62 M(-8.6%) | $77.62 M(+5.6%) |
| Sep 2020 | - | $73.53 M(-2.2%) |
| Jun 2020 | - | $75.19 M(-3.1%) |
| Mar 2020 | - | $77.56 M(-8.7%) |
| Dec 2019 | $84.96 M | $84.96 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $83.51 M(-11.7%) |
| Jun 2019 | - | $94.56 M(-0.2%) |
| Mar 2019 | - | $94.70 M(+1.5%) |
| Dec 2018 | $93.31 M(-15.1%) | $93.31 M(-18.2%) |
| Sep 2018 | - | $114.08 M(-2.9%) |
| Jun 2018 | - | $117.55 M(-3.9%) |
| Mar 2018 | - | $122.33 M(+11.2%) |
| Dec 2017 | $109.97 M(+6.2%) | $109.97 M(+2.4%) |
| Sep 2017 | - | $107.41 M(-0.8%) |
| Jun 2017 | - | $108.33 M(-1.1%) |
| Mar 2017 | - | $109.57 M(+5.8%) |
| Dec 2016 | $103.58 M(+60.1%) | $103.58 M(-0.7%) |
| Sep 2016 | - | $104.35 M(+0.0%) |
| Jun 2016 | - | $104.30 M(-15.5%) |
| Mar 2016 | - | $123.42 M(+90.7%) |
| Dec 2015 | $64.71 M(+4.0%) | $64.71 M(-3.6%) |
| Sep 2015 | - | $67.16 M(+6.5%) |
| Jun 2015 | - | $63.08 M(-7.9%) |
| Mar 2015 | - | $68.47 M(+10.0%) |
| Dec 2014 | $62.22 M(+133.1%) | $62.22 M |
| Dec 2013 | $26.70 M | - |
FAQ
- What is Zevra Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Zevra Therapeutics?
- What is Zevra Therapeutics annual total liabilities year-on-year change?
- What is Zevra Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly total liabilities year-on-year change?
What is Zevra Therapeutics annual total liabilities?
The current annual total liabilities of ZVRA is $110.46 M
What is the all time high annual total liabilities for Zevra Therapeutics?
Zevra Therapeutics all-time high annual total liabilities is $110.46 M
What is Zevra Therapeutics annual total liabilities year-on-year change?
Over the past year, ZVRA annual total liabilities has changed by +$70.24 M (+174.65%)
What is Zevra Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ZVRA is $121.78 M
What is the all time high quarterly total liabilities for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly total liabilities is $123.42 M
What is Zevra Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ZVRA quarterly total liabilities has changed by +$11.32 M (+10.25%)